Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Not All Discharge Settings Are Created Equal: Thirty-Day Readmission Risk after Elective Colorectal Surgery.
Pain Care in the Department of Veterans Affairs: Understanding How a Cultural Shift in Pain Care Impacts Provider Decisions and Collaboration.
A long-acting human growth hormone (Nutropin Depot): efficacy and safety following two years of treatment in children with growth hormone deficiency.
Maternal expression and early induction of histone gene transcription factor Hinfp sustains development in pre-implantation embryos.
Immunotherapy of malignant diseases. Challenges and strategies.
See All 17 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunotherapy of malignant diseases. Challenges and strategies.
Ko EC, Wang X, Ferrone S. Immunotherapy of malignant diseases. Challenges and strategies. Int Arch Allergy Immunol. 2003 Dec; 132(4):294-309.
View in:
PubMed
subject areas
Animals
Antibodies, Monoclonal
Antigens, Neoplasm
Humans
Immunization, Passive
Immunotherapy, Active
Mice
Neoplasms
T-Lymphocytes, Cytotoxic